U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07165158) titled 'The Effect of Semaglutide on Bone Health' on Sept. 01.
Brief Summary: Semaglutide has effects that include lowering blood sugar, reducing weight, and improving cardiovascular and renal outcomes, and it is now widely used in clinical practice. Given that weight loss is associated with bone loss, its effect on bone health has recently raised concerns. Therefore, the goal of this clinical trial is to learn the effect of semaglutide on bone mineral density and fractures in patients with type 2 diabetes.
We will compare semaglutide combined with metformin to metformin alone to see if semaglutide treatment has effects on bone mineral de...